Events

Loading events…

FDA decision: Ivonescimab by Summit Therapeutics (in 2026)

OtherOPEN

FDA decision: Ivonescimab by Summit Therapeutics (in 2026)

Closes4:59 AM UTCFri, Jan 1, 2027

Rules

If the FDA's decision on Ivonescimab by Summit Therapeutics in 2026 is a full approval or an accelerated approval, the market resolves to Yes.

Resolver0x15...4B4dExplorer ↗

Exchange0x7d...D7E7Explorer ↗

NetworkPolygon PoS (Chain 137)

CreatedSep 9, 2026 · 4:05 AM

ExpiresJan 1, 2027 · 4:59 AM

Open book

a full approval or an accelerated approval

Order ticket

Select a market to start trading